FDA alerts providers to COVID-19 rapid test recall
The Food and Drug Administration last week announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved. Due to the potential for false results, FDA said health care providers and testing programs should consider retesting patients with an authorized test if they administered the CovClear COVID-19 Rapid Antigen Test less than two weeks ago and suspect an inaccurate result, or administered the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test and suspect a recent or prior COVID-19 infection.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…